Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

Recruiting

Phase 1

Phase 2

PF-08634404Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

Sponsor:

Pfizer

Code:

NCT07421700

Conditions

Urothelial Cancer

Advanced/Metastatic Urothelial Cancer

Urothelial Carcinoma

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

PF-08634404

Enfortumab Vedotin

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information

Trial information was received from ClinicalTrials.gov and was last updated on 2026-04-22. This information was provided to ClinicalTrials.gov by Pfizer on 2026-04-20.